Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 31 | 2025 | 450 | 6.030 |
Why?
|
| Autistic Disorder | 27 | 2026 | 398 | 4.550 |
Why?
|
| Chromosomes, Human, Pair 16 | 13 | 2026 | 147 | 1.970 |
Why?
|
| Chromosome Disorders | 9 | 2026 | 316 | 1.460 |
Why?
|
| Child Development Disorders, Pervasive | 7 | 2015 | 82 | 1.160 |
Why?
|
| Developmental Disabilities | 9 | 2025 | 781 | 1.150 |
Why?
|
| Parents | 12 | 2023 | 1128 | 1.050 |
Why?
|
| Intellectual Disability | 8 | 2026 | 1089 | 1.020 |
Why?
|
| Chromosome Deletion | 13 | 2026 | 653 | 0.940 |
Why?
|
| Vaccines | 3 | 2020 | 388 | 0.890 |
Why?
|
| Phenotype | 14 | 2020 | 4497 | 0.870 |
Why?
|
| DNA Copy Number Variations | 10 | 2021 | 1029 | 0.790 |
Why?
|
| Chromosome Duplication | 6 | 2020 | 146 | 0.710 |
Why?
|
| Child | 48 | 2026 | 26341 | 0.670 |
Why?
|
| Verbal Behavior | 1 | 2020 | 45 | 0.640 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2021 | 919 | 0.600 |
Why?
|
| Paternal Behavior | 1 | 2019 | 11 | 0.600 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 22 | 0.590 |
Why?
|
| Maternal Behavior | 1 | 2019 | 66 | 0.570 |
Why?
|
| Heterozygote | 7 | 2021 | 737 | 0.560 |
Why?
|
| Hormones | 1 | 2019 | 162 | 0.560 |
Why?
|
| Anxiety | 5 | 2025 | 1014 | 0.540 |
Why?
|
| Adolescent | 34 | 2026 | 20987 | 0.510 |
Why?
|
| Sex Characteristics | 1 | 2019 | 323 | 0.510 |
Why?
|
| Intelligence | 5 | 2015 | 103 | 0.480 |
Why?
|
| Child, Preschool | 28 | 2026 | 15110 | 0.470 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2019 | 248 | 0.470 |
Why?
|
| Symbolism | 1 | 2015 | 2 | 0.460 |
Why?
|
| Patient Advocacy | 1 | 2015 | 60 | 0.450 |
Why?
|
| Vaccination | 3 | 2020 | 1060 | 0.420 |
Why?
|
| Humans | 61 | 2026 | 131163 | 0.420 |
Why?
|
| Male | 44 | 2026 | 64957 | 0.390 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 63 | 0.380 |
Why?
|
| Psychotropic Drugs | 2 | 2019 | 123 | 0.360 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2020 | 629 | 0.360 |
Why?
|
| Social Behavior | 2 | 2015 | 214 | 0.350 |
Why?
|
| Female | 39 | 2026 | 70963 | 0.340 |
Why?
|
| Referral and Consultation | 3 | 2022 | 564 | 0.330 |
Why?
|
| Sequence Deletion | 2 | 2019 | 516 | 0.330 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2020 | 23 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 3436 | 0.310 |
Why?
|
| Speech Therapy | 1 | 2019 | 14 | 0.290 |
Why?
|
| Occupational Therapy | 1 | 2019 | 37 | 0.290 |
Why?
|
| Cognition | 5 | 2020 | 829 | 0.290 |
Why?
|
| Family Health | 2 | 2014 | 240 | 0.290 |
Why?
|
| Checklist | 1 | 2019 | 97 | 0.280 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 280 | 0.280 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 338 | 0.280 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 2 | 2025 | 10 | 0.270 |
Why?
|
| Creatine | 2 | 2025 | 37 | 0.270 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2025 | 26 | 0.270 |
Why?
|
| Oxytocin | 2 | 2019 | 68 | 0.270 |
Why?
|
| Brain | 2 | 2019 | 3175 | 0.260 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 52 | 0.250 |
Why?
|
| Epilepsy | 2 | 2023 | 876 | 0.250 |
Why?
|
| Behavior Therapy | 1 | 2019 | 273 | 0.240 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2026 | 4 | 0.240 |
Why?
|
| Siblings | 3 | 2020 | 201 | 0.240 |
Why?
|
| Language | 2 | 2020 | 219 | 0.240 |
Why?
|
| Baclofen | 1 | 2026 | 44 | 0.240 |
Why?
|
| Depression | 1 | 2025 | 1320 | 0.240 |
Why?
|
| Psychometrics | 4 | 2020 | 678 | 0.230 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 32 | 0.230 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 29 | 0.220 |
Why?
|
| Self-Injurious Behavior | 1 | 2016 | 67 | 0.220 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2025 | 81 | 0.220 |
Why?
|
| Proteins | 1 | 2020 | 1006 | 0.220 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 963 | 0.210 |
Why?
|
| Motion Perception | 1 | 2015 | 59 | 0.210 |
Why?
|
| Adult | 16 | 2025 | 31282 | 0.200 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 174 | 0.200 |
Why?
|
| Models, Neurological | 1 | 2015 | 212 | 0.200 |
Why?
|
| Movement Disorders | 1 | 2025 | 218 | 0.190 |
Why?
|
| Sibling Relations | 1 | 2012 | 12 | 0.190 |
Why?
|
| Precision Medicine | 1 | 2026 | 388 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 36 | 0.180 |
Why?
|
| Social Adjustment | 1 | 2012 | 77 | 0.180 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 59 | 0.180 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 731 | 0.180 |
Why?
|
| Carnitine | 1 | 2012 | 70 | 0.180 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 960 | 0.170 |
Why?
|
| Faculty | 1 | 2012 | 99 | 0.170 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 155 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 204 | 0.170 |
Why?
|
| Consumer Product Safety | 1 | 2010 | 29 | 0.160 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 125 | 0.160 |
Why?
|
| Syringomyelia | 1 | 2010 | 17 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 223 | 0.160 |
Why?
|
| Young Adult | 8 | 2025 | 10103 | 0.160 |
Why?
|
| Speech | 1 | 2020 | 63 | 0.150 |
Why?
|
| Pediatrics | 1 | 2019 | 1252 | 0.150 |
Why?
|
| Emotions | 1 | 2012 | 350 | 0.150 |
Why?
|
| Arginine Vasopressin | 1 | 2019 | 26 | 0.150 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 63 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 142 | 0.140 |
Why?
|
| Folic Acid | 1 | 2010 | 269 | 0.140 |
Why?
|
| Intelligence Tests | 2 | 2015 | 62 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 573 | 0.130 |
Why?
|
| Fixation, Ocular | 1 | 2017 | 19 | 0.130 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 23 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 2007 | 86 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 330 | 0.130 |
Why?
|
| Child Behavior | 1 | 2009 | 232 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2010 | 448 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2025 | 1490 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 526 | 0.130 |
Why?
|
| Family | 1 | 2020 | 589 | 0.120 |
Why?
|
| Language Development Disorders | 2 | 2013 | 177 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 776 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2020 | 1445 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2017 | 148 | 0.120 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 4066 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2019 | 311 | 0.120 |
Why?
|
| Motor Skills | 1 | 2015 | 72 | 0.110 |
Why?
|
| Aptitude | 1 | 2015 | 11 | 0.110 |
Why?
|
| Pedigree | 4 | 2017 | 1677 | 0.110 |
Why?
|
| Caregivers | 2 | 2022 | 598 | 0.110 |
Why?
|
| Consensus | 2 | 2025 | 512 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 145 | 0.110 |
Why?
|
| Executive Function | 1 | 2015 | 122 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2016 | 358 | 0.110 |
Why?
|
| Infant | 6 | 2025 | 13352 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2022 | 844 | 0.100 |
Why?
|
| Communication | 2 | 2022 | 543 | 0.100 |
Why?
|
| Mutation | 1 | 2017 | 6099 | 0.100 |
Why?
|
| Testosterone | 1 | 2019 | 531 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 645 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 314 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 3061 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2016 | 324 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 63 | 0.090 |
Why?
|
| Middle Aged | 6 | 2025 | 28601 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12936 | 0.090 |
Why?
|
| Neurophysiology | 1 | 2012 | 22 | 0.090 |
Why?
|
| Asperger Syndrome | 3 | 2011 | 8 | 0.090 |
Why?
|
| Syndrome | 2 | 2020 | 1155 | 0.080 |
Why?
|
| Pediatricians | 1 | 2022 | 78 | 0.080 |
Why?
|
| Seizures | 1 | 2016 | 890 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3359 | 0.080 |
Why?
|
| Texas | 2 | 2021 | 3686 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2012 | 194 | 0.080 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2020 | 63 | 0.080 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 32 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2006 | 1050 | 0.070 |
Why?
|
| Base Sequence | 1 | 2013 | 2730 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2013 | 830 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 214 | 0.070 |
Why?
|
| Age of Onset | 2 | 2015 | 592 | 0.070 |
Why?
|
| Neuroimaging | 1 | 2012 | 385 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2026 | 1626 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2021 | 767 | 0.070 |
Why?
|
| School Health Services | 1 | 2019 | 103 | 0.070 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 11 | 0.070 |
Why?
|
| Minority Groups | 1 | 2020 | 260 | 0.070 |
Why?
|
| Genes, Essential | 1 | 2017 | 39 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 588 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2017 | 222 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2014 | 910 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 716 | 0.060 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 13 | 0.060 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 14 | 0.060 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 33 | 0.060 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 14 | 0.060 |
Why?
|
| Exons | 2 | 2013 | 759 | 0.060 |
Why?
|
| Hepatitis B Vaccines | 1 | 2016 | 49 | 0.060 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2016 | 35 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 915 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1106 | 0.050 |
Why?
|
| Canada | 1 | 2016 | 327 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 819 | 0.050 |
Why?
|
| North America | 1 | 2015 | 255 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2025 | 180 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17753 | 0.050 |
Why?
|
| Photic Stimulation | 1 | 2015 | 227 | 0.050 |
Why?
|
| Chromatin | 1 | 2017 | 499 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 283 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 231 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 11074 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 2825 | 0.050 |
Why?
|
| Internal-External Control | 1 | 2012 | 73 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2012 | 113 | 0.040 |
Why?
|
| Penetrance | 1 | 2012 | 107 | 0.040 |
Why?
|
| Reference Values | 1 | 2012 | 676 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2021 | 101 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 464 | 0.040 |
Why?
|
| Animals | 1 | 2019 | 33912 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2007 | 46 | 0.030 |
Why?
|
| Socialization | 1 | 2007 | 20 | 0.030 |
Why?
|
| Individuality | 1 | 2007 | 40 | 0.030 |
Why?
|
| United States | 2 | 2016 | 12072 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 7512 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2085 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2009 | 928 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 130 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 124 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 258 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2009 | 1211 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 105 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 81 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 143 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2016 | 135 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2701 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 386 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 2595 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 121 | 0.020 |
Why?
|
| Microcephaly | 1 | 2016 | 347 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 80 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 422 | 0.020 |
Why?
|
| Cerebellum | 1 | 2016 | 441 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2011 | 86 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1882 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1595 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3464 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1634 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5196 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4886 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21025 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1797 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5063 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 1717 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3763 | 0.010 |
Why?
|